A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening

Abstract excerpt

screening platform, VirtualFlow, to search for inhibitors that target SARS-CoV-2. In this unprecedented structure-based virtual campaign, we screened roughly 1 billion molecules against each of 40 different target sites on 17 different potential viral and host targets. In addition to targeting the active sites of viral enzymes, we also targeted critical auxiliary sites such as functionally important...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computational Drug Discovery Methods
• Share to SARS-CoV-2 and COVID-19 Research
• Share to vaccines and immunoinformatics approaches